Health Technology Assessment (HTA) is an instrumental part of the process in obtaining reimbursement and market access for pharmaceuticals and medical products in countries around the world. This webinar will consist of presentations as well as a moderated panel discussion with experts to discuss relevant HTA topics including some of the key challenges that recent scientific advances and new data sources create for different stakeholders.

The Basel Biometric Society (BBS) and the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) are pleased to host a scientific meeting on this relevant topic with experts from the pharmaceutical industry, academia and the European HTA bodies.

Click here for additional information and registration details.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.